Increasing Serum IL-17F Levels in Pediatric Localized Scleroderma As Disease Enters Remission.
Publication
, Conference
Torok, KS; Kurzinski, K; Kelsey, C; Feghali-Bostwick, CA
Published in: ARTHRITIS AND RHEUMATISM
2011
Duke Scholars
Published In
ARTHRITIS AND RHEUMATISM
EISSN
1529-0131
ISSN
0004-3591
Publication Date
2011
Volume
63
Issue
10
Start / End Page
S712 / S713
Related Subject Headings
- Arthritis & Rheumatology
- 1117 Public Health and Health Services
- 1107 Immunology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Torok, K. S., Kurzinski, K., Kelsey, C., & Feghali-Bostwick, C. A. (2011). Increasing Serum IL-17F Levels in Pediatric Localized Scleroderma As Disease Enters Remission. In ARTHRITIS AND RHEUMATISM (Vol. 63, pp. S712–S713).
Torok, Kathryn S., Katherine Kurzinski, Christina Kelsey, and Carol A. Feghali-Bostwick. “Increasing Serum IL-17F Levels in Pediatric Localized Scleroderma As Disease Enters Remission.” In ARTHRITIS AND RHEUMATISM, 63:S712–13, 2011.
Torok KS, Kurzinski K, Kelsey C, Feghali-Bostwick CA. Increasing Serum IL-17F Levels in Pediatric Localized Scleroderma As Disease Enters Remission. In: ARTHRITIS AND RHEUMATISM. 2011. p. S712–3.
Torok, Kathryn S., et al. “Increasing Serum IL-17F Levels in Pediatric Localized Scleroderma As Disease Enters Remission.” ARTHRITIS AND RHEUMATISM, vol. 63, no. 10, 2011, pp. S712–13.
Torok KS, Kurzinski K, Kelsey C, Feghali-Bostwick CA. Increasing Serum IL-17F Levels in Pediatric Localized Scleroderma As Disease Enters Remission. ARTHRITIS AND RHEUMATISM. 2011. p. S712–S713.
Published In
ARTHRITIS AND RHEUMATISM
EISSN
1529-0131
ISSN
0004-3591
Publication Date
2011
Volume
63
Issue
10
Start / End Page
S712 / S713
Related Subject Headings
- Arthritis & Rheumatology
- 1117 Public Health and Health Services
- 1107 Immunology
- 1103 Clinical Sciences